阴性sestamibi扫描影响内分泌科和外科医生对甲状旁腺手术的决策
本研究通过区域医疗系统2年数据,分析539例原发性甲状旁腺功能亢进患者,发现阴性sestamibi扫描独立降低内分泌科转诊外科(OR=0.36)和外科推荐手术(OR=0.32)的可能性,但术后治愈率98%且不受扫描结果影响。
要点
- 术后治愈率98%,与sestamibi结果无关。
核心结论
- 阴性sestamibi扫描影响内分泌科转诊和外科手术决策,但术后治愈率优秀。
研究设计与样本
- 回顾性队列研究,纳入区域医疗系统2年内539例原发性甲状旁腺功能亢进患者。
主要发现
- 452例由内分泌科医生诊治,其中260例完成sestamibi扫描(120例阴性,140例阳性),201例(77%)转诊外科。
- 调整经典症状、年龄、手术适合性、钙、甲状旁腺激素、肾小球滤过率和骨密度后,阴性扫描与未转诊外科独立相关(OR=0.36;95%CI 0.18-0.73)。
- 外科医生接诊255例(包括非内分泌科转诊),推荐手术236例;阴性扫描与未推荐手术独立相关(OR=0.32;95%CI 0.11-0.91)。
- 211/255例完成手术,术后治愈率98%,不受sestamibi结果影响。
临床怎么用
- 内分泌科和外科医生应意识到阴性sestamibi扫描不应作为拒绝转诊或手术的理由,因为术后治愈率仍高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It has been observed that negative sestamibi scans may impact practice patterns in patients with primary hyperparathyroidism. However, there are no published data on the issue. The objective was to elucidate the influence of negative sestamibi scans on referrals by endocrinologists for parathyroidectomy and surgeon decision-making. METHODS: All patients with primary hyperparathyroidism were identified within a region-wide health care system over a 2-year period. Data, including age, calcium, parathyroid hormone, renal function, bone density, and sestamibi scan results, were collected from the electronic medical record of all patients. The electronic referral system was used to track consultations with endocrinologists and surgeons. Multivariable logistic regression analysis was done to model factors involved in endocrinologist recommendations (referral or no referral to operation) and surgeon recommendations (parathyroidectomy or no parathyroidectomy). RESULTS: A total of 539 patients with primary hyperparathyroidism were identified, and 452 were seen by endocrinologists. Of these, 260 patients had sestamibi scans done (120 negative and 140 positive), and 201 (77%) patients were referred to surgeons. Compared with positive sestamibi scans, negative sestamibi scans were independently associated with no referral to surgeons, after adjusting for presence of classic symptoms, age, fitness for operation, calcium, parathyroid hormone, glomerular filtration rate, and bone density (odds ratio = 0.36; 95% confidence interval 0.18-0.73). Surgeons saw an additional 54 patients referred from nonendocrinologists or primary care physicians and sestamibi scans were completed. Surgeons recommended parathyroidectomy in 236 of the 255 patients. Negative sestamibi scans were independently associated with no recommendation for operation (odds ratio = 0.32; 95% confidence interval 0.11-0.91). Surgeons initially scheduled and completed parathyroidectomies in 211/255 patients. Cure rate after operation was 98%, and this was not influenced by the sestamibi scan result. CONCLUSION: Negative sestamibi scans influence decision making in the management of patients with primary hyperparathyroidism. Endocrinologists commonly order sestamibi scans, and if negative, they are less likely to refer patients to surgeons. Surgeons are also influenced by sestamibi scans, and if negative, they are less likely to recommend parathyroidectomy. Cure rate in sestamibi-negative patients is excellent after operation.
引用
- Wu S, Hwang SS, Haigh PI, et al. Influence of a negative sestamibi scan on the decision for parathyroid operation by the endocrinologist and surgeon. Surgery. 2016. PMID: 27842909. doi:10.1016/j.surg.2016.05.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。